Stock NRGXQ NEUROLOGIX, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Neurologix, Inc.

Equities

NRGXQ

US64125U4067

Biotechnology & Medical Research

Delayed OTC Markets
Other stock markets
 		5-day change 1st Jan Change
- USD -.--% Intraday chart for Neurologix, Inc. -.--% -.--%

Business Summary

Neurologix, Inc. engages in the research and development of gene transfer therapies for the treatment for brain disorders and central nervous system diseases. The company programs address conditions such as Parkinson's disease, epilepsy, depression and Huntington's disease.

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 734,898 0 0 100.00 %
Stock B 0 275,235 0 0
Stock C 1 27,997,701 27,997,701 ( 100.00 %) 0
Stock D 0 645 0 0

Company contact information

Neurologix, Inc.

1 Bridge Plaza

07024, Fort Lee

+

http://www.neurologix.net
address Neurologix, Inc.(NRGXQ)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
MODERNA, INC. Stock Moderna, Inc.
+27.67% 48.16B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-0.96% 41.73B
LONZA GROUP AG Stock Lonza Group AG
+43.45% 41.03B
CELLTRION, INC. Stock Celltrion, Inc.
-5.26% 28.77B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+10.00% 25.59B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-22.94% 18.96B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+7.99% 12.92B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+29.11% 12.03B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-2.17% 11.77B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. NRGXQ Stock
  4. Company Neurologix, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW